Navigation Links
First Quarter 2008 Financial Results Announcement and Teleconference
Date:4/16/2008

PHILADELPHIA, April 16 /PRNewswire-FirstCall/ -- On Wednesday, April 23, 2008, GlaxoSmithKline plc will announce its first quarter financial results for the three months ended March 31, 2008. The announcement is scheduled to be released to the London Stock Exchange at approximately 7:00 am (ET) US and will be available on the website: http://www.gsk.com shortly thereafter.

Following the announcement, JP Garnier, Chief Executive Officer and Julian Heslop, Chief Financial Officer, will hold a global teleconference for analysts and investors. You are invited to listen in to this presentation of the first quarter 2008 results. This teleconference will take place on:

Wednesday, April 23rd at 9:00 am ET

To participate in the teleconference please dial:

U.S. Toll Free Phone +1 877 491 0064

Please quote: GSK Q1 Results

A recording of the teleconference will be available from 1:00 pm ET on April 23rd (until April 30th) on:

U.S. Toll Free phone + 1 888 365 0240

Passcode: 792110

GSK will host a live audio webcast of the results presentation with synchronized slides. It will begin at the same time as the teleconference, 9:00 am ET, and can be accessed directly via the GlaxoSmithKline website: http://gsk.com. Slides will be available shortly before the teleconference on the GSK website.

An archived version of this webcast will be available from the corporate website at approximately 3:00 pm ET on the same day.


'/>"/>
SOURCE GlaxoSmithKline plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... This report is a professional and ... an overview analysis, the report introduces quartz tubing ... industry overview, policy analysis, and news analysis, etc. ... witnessed rapid development with key manufacturers increasing their ... mentions quartz tubing upstream raw materials and equipment, ...
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... 16, 2014  Vermillion, Inc. (NASDAQ: VRML ... today announced the next step in its expanded strategy ... provider with the naming of current Chief Operating Officer, ... Officer, while current Chairman of the Board and CEO ... Chairman. These changes are effective January 1, 2015. ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ... targeting the extracellular matrix for the endocrinology, oncology, ... of $5.5 million from Baxter Healthcare Corporation representing ... terms of its HYLENEX licensing agreement, which provides ...
... ST. JOSEPH, Mich., Jan. 6 GeneGo, Inc., ... curated databases for systems biology,and pathway analysis ... has,renewed its MetaCore licenses for another three years. ... diseases and gynecological therapies,and GeneGo has good coverage ...
... 6 WuXi AppTec, the operating company of WuXi ... and development outsourcing company with operations in China and ... from ThalesNano Inc. for laboratory-based hydrogenation. WuXi joins ... have introduced and adopted the H-Cube technology. , ...
Cached Biology Technology:GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years 2WuXi AppTec Selects H-Cube from ThalesNano for Laboratory-based Hydrogenation 2
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014   Atmel® ... leader in microcontroller (MCU) and touch technology solutions, today ... temperature sensors with the widest V cc ... higher temperature accuracy and faster I 2 C bus ... and serial EEPROM memory making them ideal for consumer, ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... Increased summer precipitation apparently helping to spread spores of ... pines in northwestern British Columbia present strong evidence in ... to blame for the outbreak. The blight, caused by ... needles and, in the case of the British Columbia ...
... adult brain can reorganize neural pathways in response to ... and responses of neurons. But it has remained an ... In a new study published in the open-access journal ... continuous monitoring of neurons in the mouse adult visual ...
... the Fungal Research Trust have discovered millions of fungal ... , Aspergillus fumigatus, the species ... to cause disease; and the resulting condition Aspergillosis has ... and bone marrow transplant patients. Fungi also exacerbate asthma ...
Cached Biology News:A new window into structural plasticity in the adult visual cortex 2Pillows - a hot bed of fungal spores 2
Indoleamine 2,3-dioxygenase [IDO]...
... Mouse monoclonal [F30 P7 D7 F5] ... all tested applications). ... to Ovalbumin, corresponding to amino acids ... Entrez Gene ID: ...
Recognizes the 41 and 43 kDa G-proteins present in liver plasma membranes and Gq/11alpha expressed in the Sf9 insect cell expression system. Negative for recombinant G(I)alpha subtypes....
Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014)....
Biology Products: